{"id":"W1497402064","doi":"10.1200/jco.2012.46.1764","title":"Symptom control and quality of life in LUX-Lung 3: a phase III study of afatinib or cisplatin/pemetrexed in patients with advanced lung adenocarcinoma with EGFR mutations.","year":2013,"lang":"en","type":"article","venue":"PubMed","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University","funders":"","keywords":"Afatinib; Pemetrexed; Medicine; Lung cancer; Internal medicine; Quality of life (healthcare); Adenocarcinoma; Oncology; Cisplatin; Chemotherapy; Nausea; Cancer; Epidermal growth factor receptor; Gefitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002703336,0.001375313,0.002957415,0.000328443,0.0003998686,0.0008753025,0.0009960192,0.001352703,0.002839385],"category_scores_gemma":[0.001706149,0.0006294787,0.002802519,0.0004435426,0.001160595,0.0007485386,0.0004030554,0.003127708,0.0005151103],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000946185,"about_ca_system_score_gemma":0.001404065,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00105655,"about_ca_topic_score_gemma":0.00272189,"domain_scores_codex":[0.9989543,0.000624494,0.00005973771,0.000119365,0.0000941121,0.0001479708],"domain_scores_gemma":[0.9985402,0.0003180127,0.0003762127,0.0001020716,0.00007229528,0.0005912191],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9237472,0.02661116,0.007997285,0.0006809896,0.001933319,0.0000961157,0.0001262379,0.000883368,0.007578891,0.00005826932,0.0008238773,0.02946329],"study_design_scores_gemma":[0.8407795,0.1443613,0.01259291,0.0000153934,0.0005569017,0.0000944373,0.00002362268,0.0005154132,0.0006586435,0.000055259,0.0003301071,0.00001649865],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960178,0.001779747,0.0002075748,0.0002744064,0.00005863679,0.0009293883,0.0003682495,0.00002557219,0.0003385906],"genre_scores_gemma":[0.9952166,0.0009780347,0.0006743061,0.0004892068,0.0001073324,0.001374528,0.0006616234,0.000008508427,0.000489905],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002957415,"threshold_uncertainty_score":0.01429677,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01654936719525221,"score_gpt":0.3026509365360581,"score_spread":0.2861015693408059,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}